Schedule 13G ownership disclosure
ARCA BIOPHARMA INC
Security class unavailable · CUSIP: 00211Y506
Event date: 2023-08-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-232441
- Form type
- SC 13G
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Sep 11, 2023
- Reporting period
- Aug 30, 2023
- Description
- Schedule 13G beneficial ownership